Well worth North of a $100m ,,,,, once Human Trials begin PAA...

Well worth North of a $100m ,,,,, once Human Trials begin PAA are a Phase II company in the feild of Oncology, MND and SARs.
The Leiden data is crucial as I understand it with gaining the data that will assist greatly with calculating a Human dose and possible dosing duration.

Once the dose has been calculated it is a walk to have a pill manufactured by the likes of BRI.. In the past PAA has opted for GMP Batch pills (not an R and D prototype bespoke batch) this is so they have continuity in the trial pills and should we gain positive results they are able to begin manufacturing immediately,...

ONJF trial data must be close , I noted last time they trialed it was circa 90 days from when they announced..

I feel the tide has turned and PAA should begin its climb back into the high teens to mid 20's..... the smart money starts to get on board when they see the Horizon filled with Trials and Pending data....

And the Leiden data ,,as far as I'm concerned will make it 4 from 4 .

WEHI 1, Positive , 50% reduction in 24 hours , 95% reduction in 72 Hours
WEHI 2 "Remarkable" from Australia's leading Virologist " plus this was picked up by Rueters News agency ,,
Biolabs 360, again showing the same positive effects..
Leiden ,,,, just see this as another opportunity to gather positive data....

Then it would be great to have some Australian Governement or Agency recognition to assist with fast tracking and an injection of Funds to assist the Team...

Best of Luck
Drag Racing tomorrow at Masteron Motorplex , car is singing
NZT